India Next Generation Sequencing Market Size, Share, and Trends 2026 to 2035

 Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on India Next Generation Sequencing Market

5.1. COVID-19 Landscape: Next Generation Sequencing Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. India Next Generation Sequencing Market, By Product

8.1. India Next Generation Sequencing Market, by Product Type

8.1.1. Consumables Platforms

8.1.1.1. Market Revenue and Forecast

8.1.2. Services and Nerve Blockers

8.1.2.1. Market Revenue and Forecast

Chapter 9. India Next Generation Sequencing Market, By Application

9.1. India Next Generation Sequencing Market, by Application

9.1.1. Diagnostics

9.1.1.1. Market Revenue and Forecast

9.1.2. Biomarkers and Cancer

9.1.2.1. Market Revenue and Forecast

9.1.3. Reproductive Health

9.1.3.1. Market Revenue and Forecast

9.1.4. Personalized Medicine

9.1.4.1. Market Revenue and Forecast

9.1.5. Agriculture and Animal Research

9.1.5.1. Market Revenue and Forecast

9.1.6. Others

9.1.6.1. Market Revenue and Forecast

Chapter 10. India Next Generation Sequencing Market, By Technology Type 

10.1. India Next Generation Sequencing Market, by Technology Type

10.1.1. Sequencing by Synthesis

10.1.1.1. Market Revenue and Forecast

10.1.2. Ion Semiconductor Sequencing

10.1.2.1. Market Revenue and Forecast

10.1.3. Sequencing by Ligation

10.1.3.1. Market Revenue and Forecast

10.1.4. Pyrosequencing

10.1.4.1. Market Revenue and Forecast

10.1.5. Single Molecule Real Time Sequencing

10.1.5.1. Market Revenue and Forecast

10.1.6. Others

10.1.6.1. Market Revenue and Forecast

Chapter 11. India Next Generation Sequencing Market, By End User Type 

11.1. India Next Generation Sequencing Market, by End User Type

11.1.1. Academic and Research Centers

11.1.1.1. Market Revenue and Forecast

11.1.2. Pharmaceutical and Biotechnology Companies

11.1.2.1. Market Revenue and Forecast

11.1.3. Hospitals and Clinics

11.1.3.1. Market Revenue and Forecast

11.1.4. Clinical Research

11.1.4.1. Market Revenue and Forecast

11.1.5. Others

11.1.5.1. Market Revenue and Forecast

Chapter 12. India Next Generation Sequencing Market, Regional Estimates and Trend Forecast

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Product

12.3.5.2. Market Revenue and Forecast, by Application

12.3.5.3. Market Revenue and Forecast, by Technology Type

12.3.5.4. Market Revenue and Forecast, by End User Type 

Chapter 13. Company Profiles

13.1. BGI Group

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. F. Hoffmann-La Roche AG

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Pacific Biosciences of California Inc.

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Thermo Fisher Scientific Inc.

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Agilent Technologies Inc.

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Precigen Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Illumina Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Qiagen N.V.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. PerkinElmer Inc.

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. PierianDx Inc.

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms